Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 8, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	240,089	297,962	170,528	81,683	-	-
Market Cap Growth	-30.77%	74.73%	108.77%	-	-	-
Enterprise Value	281,158	341,742	209,922	130,128	-	-
Last Close Price	180.81	224.60	128.72	66.76	-	-
PE Ratio	-	326.96	956.95	-	-	-
Forward PE	103.94	70.54	42.33	40.39	-	-
PS Ratio	2.69	3.26	2.09	1.15	-	-
PB Ratio	2.97	3.67	2.15	1.21	-	-
P/TBV Ratio	6.15	11.28	6.97	3.51	-	-
P/FCF Ratio	31.59	130.73	58.30	-	-	-
P/OCF Ratio	15.03	33.39	16.98	16.88	-	-
PEG Ratio	1.15	1.58	1.58	1.35	-	-
EV/Sales Ratio	3.15	3.73	2.57	1.84	-	-
EV/EBITDA Ratio	23.46	24.92	18.43	22.58	-	-
EV/EBIT Ratio	71.12	54.01	45.62	-	-	-
EV/FCF Ratio	37.00	149.94	71.77	-	-	-
Debt / Equity Ratio	0.60	0.60	0.60	0.83	0.62	0.54
Debt / EBITDA Ratio	4.29	3.44	4.00	9.21	3.63	2.30
Debt / FCF Ratio	6.38	21.31	16.10	-	-	-
Asset Turnover	0.57	0.59	0.55	0.52	0.57	-
Inventory Turnover	1.34	1.58	1.69	1.94	1.87	-
Quick Ratio	0.66	0.75	0.61	0.64	0.69	0.82
Current Ratio	1.43	1.54	1.25	1.26	1.34	1.47
Return on Equity (ROE)	-0.30%	1.14%	0.24%	-2.77%	6.11%	-
Return on Assets (ROA)	1.31%	2.55%	1.93%	-0.20%	2.96%	-
Return on Capital (ROIC)	1.60%	3.09%	2.30%	-0.24%	3.60%	-
Return on Capital Employed (ROCE)	2.70%	5.30%	4.20%	-0.40%	5.70%	10.50%
Earnings Yield	-0.10%	0.31%	0.10%	-2.28%	-	-
FCF Yield	3.17%	0.77%	1.71%	-5.89%	-	-
Dividend Yield	0.08%	0.06%	0.08%	-	-	-
Payout Ratio	-	15.88%	-	-	13.30%	-
Buyback Yield / Dilution	-0.21%	-3.67%	-7.85%	-0.95%	-87.83%	-
Total Shareholder Return	-0.13%	-3.61%	-7.76%	-0.95%	-87.83%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.